These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19857795)

  • 1. What happened: the chemistry side of the incident with EMS contamination in Viracept tablets.
    Gerber C; Toelle HG
    Toxicol Lett; 2009 Nov; 190(3):248-53. PubMed ID: 19857795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Viracept (nelfinavir)--ethyl methanesulfonate case: a threshold risk assessment for human exposure to a genotoxic drug contamination?
    Lutz WK
    Toxicol Lett; 2009 Nov; 190(3):239-42. PubMed ID: 19695319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMS in Viracept--the course of events in 2007 and 2008 from the non-clinical safety point of view.
    Müller L; Singer T
    Toxicol Lett; 2009 Nov; 190(3):243-7. PubMed ID: 19857794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Viracept-EMS case: impact and outlook.
    Walker VE; Casciano DA; Tweats DJ
    Toxicol Lett; 2009 Nov; 190(3):333-9. PubMed ID: 19866516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling of patient EMS exposure: translating pharmacokinetics of EMS in vitro and in animals into patients.
    Lavé T; Paehler A; Grimm HP; Gocke E; Müller L
    Toxicol Lett; 2009 Nov; 190(3):310-6. PubMed ID: 19695316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trace determination of ethyl methanesulfonate in Viracept 250 mg tablets by gas chromatography-mass spectrometry.
    Rebiere H; Maggio AF; Gimeno P; Levaillant D; Civade C; Bonnet PA; Tissier MH
    Pharmeur Sci Notes; 2008 Feb; 2008(1):17-20. PubMed ID: 18430402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro characterization of ethyl methanesulfonate pharmacokinetics in animals and in human.
    Lavé T; Birnböck H; Götschi A; Ramp T; Pähler A
    Toxicol Lett; 2009 Nov; 190(3):303-9. PubMed ID: 19695315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EMS in Viracept--initial ('traditional') assessment of risk to patients based on linear dose response relations.
    Gocke E; Müller L; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):266-70. PubMed ID: 19439165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General 4-week toxicity study with EMS in the rat.
    Pfister T; Eichinger-Chapelon A
    Toxicol Lett; 2009 Nov; 190(3):271-85. PubMed ID: 19442710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate.
    Gocke E; Bürgin H; Müller L; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):254-65. PubMed ID: 19857796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes are recommended in use of nelfinavir.
    Wilcox RD
    HIV Clin; 2008; 20(1):1, 4. PubMed ID: 18578034
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of sulfonate ester genotoxic impurities in imatinib mesylate by gas chromatography with mass spectrometry.
    Zhang C; Huang L; Wu Z; Chang C; Yang Z
    J Sep Sci; 2016 Sep; 39(18):3558-63. PubMed ID: 27461842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo genotoxicity of EMS: statistical assessment of the dose response curves.
    Gocke E; Wall M
    Toxicol Lett; 2009 Nov; 190(3):298-302. PubMed ID: 19857797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations regarding a permitted daily exposure calculation for ethyl methanesulfonate.
    Müller L; Gocke E
    Toxicol Lett; 2009 Nov; 190(3):330-2. PubMed ID: 19857798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA notifications. FDA provides more info in response to Viracept recall.
    AIDS Alert; 2007 Nov; 22(11):129-31. PubMed ID: 18411458
    [No Abstract]   [Full Text] [Related]  

  • 17. In-utero exposure to nelfinavir-ethyl methyl sulfone.
    Hleyhel M; Goujon S; Sibiude J; Blanche S; Warszawski J;
    AIDS; 2016 Nov; 30(17):2729-2730. PubMed ID: 27662548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an automated static headspace gas chromatography-mass spectrometry (SHS-GC-MS) method for monitoring the formation of ethyl methane sulfonate from ethanol and methane sulfonic acid.
    Jacq K; Delaney E; Teasdale A; Eyley S; Taylor-Worth K; Lipczynski A; Reif VD; Elder DP; Facchine KL; Golec S; Oestrich RS; Sandra P; David F
    J Pharm Biomed Anal; 2008 Dec; 48(5):1339-44. PubMed ID: 18996665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of GC-MS method for the determination of methyl methanesulfonate and ethyl methanesulfonate in imatinib mesylate.
    Ramakrishna K; Raman NV; Rao KM; Prasad AV; Reddy KS
    J Pharm Biomed Anal; 2008 Mar; 46(4):780-3. PubMed ID: 18178357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viracept recommended for reinstatement in Europe.
    AIDS Patient Care STDS; 2007 Oct; 21(10):780. PubMed ID: 17992722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.